Migraines affect roughly one in four women and one in twelve men at some point in their lives, making it one of the most common neurological conditions worldwide. Yet despite how widespread it is, migraine is still frequently misunderstood as “just a bad headache.” In reality, it’s a complex neurological disease involving changes in brain activity, blood vessels, and pain-signalling pathways \u2014 and the medications used to treat it reflect that complexity.<\/p>\n
This guide walks through the major categories of anti-migraine medications<\/strong>, how they work, and how doctors typically decide which approach is best for a given patient.<\/p>\n Before diving into medications, it helps to understand what’s actually happening during an attack. Migraines typically progress through four stages: a prodrome phase (subtle warning signs like fatigue or irritability), an aura phase in some patients (visual disturbances or sensory changes), the attack itself (throbbing pain, nausea, light and sound sensitivity), and a postdrome phase (a “migraine hangover” of grogginess afterwards).<\/p>\n Because migraine involves several biological mechanisms \u2014 blood vessel dilation, inflammation, and abnormal activity of the trigeminal nerve system, along with a neuropeptide called CGRP (calcitonin gene-related peptide) \u2014 treatments target different points in that process. This is why no single medication works for everyone, and why treatment is usually split into two broad categories: acute (abortive) treatment<\/strong>, taken to stop an attack once it starts, and preventive treatment<\/strong>, taken regularly to reduce the frequency of attacks in the first place.<\/p>\n For mild-to-moderate migraines, many people start with standard pain relievers: NSAIDs like ibuprofen or naproxen, or acetaminophen. These are often effective when taken early in an attack, before pain becomes severe. Some formulations combine a pain reliever with caffeine, which can enhance absorption and effectiveness.<\/p>\n The main limitation is that OTC medications frequently aren’t strong enough for moderate-to-severe migraines, and using them too frequently (generally more than 10\u201315 days a month, depending on the drug) can actually trigger a separate condition called medication-overuse headache, where the treatment itself becomes part of the problem.<\/p>\n Triptans are considered the first migraine-specific drug class and remain a mainstay of acute treatment nearly three decades after their introduction. They work by activating serotonin (5-HT1) receptors, which cause constriction of dilated blood vessels in the brain and interrupt the transmission of pain signals along the trigeminal nerve pathway.<\/p>\n Commonly used triptans include:<\/p>\n Triptans are most effective when taken at the earliest sign of an attack, rather than waiting for pain to peak. They aren’t appropriate for everyone, though \u2014 they’re generally avoided in people with uncontrolled high blood pressure, coronary artery disease, or a history of stroke, since their vessel-constricting action can pose risks in those conditions.<\/p>\n Gepants are a newer class of oral medications that block the CGRP receptor directly, interrupting one of the key pathways involved in migraine pain, without the vessel-constricting effect of triptans. This makes them a valuable option for people who can’t safely take triptans due to cardiovascular risk factors.<\/p>\n Ergotamine-based medications were among the earliest migraine-specific treatments, predating triptans by decades. They still have a role for some patients with attacks that don’t respond well to triptans, though they’ve largely been supplanted due to a narrower safety margin and more pronounced side effects like nausea.<\/p>\n Because nausea and vomiting are core migraine symptoms \u2014 not just side effects of treatment \u2014 anti-nausea medications (antiemetics) like metoclopramide or prochlorperazine are frequently prescribed alongside a primary treatment, particularly for attacks severe enough to cause vomiting.<\/p>\n Preventive treatment is generally considered when migraines occur four or more days a month, significantly disrupt daily life, or don’t respond adequately to acute treatment alone. The goal isn’t to eliminate migraines entirely but to reduce their frequency, severity, and duration.<\/p>\n For decades, migraine prevention relied on medications originally developed for other conditions:<\/p>\n These remain valid, well-studied options, particularly because of their long track record and lower cost, though they come with class-specific side effects (such as fatigue with beta-blockers or cognitive effects with topiramate) that don’t suit every patient.<\/p>\n The most significant shift in migraine prevention over the past several years has been the arrival of CGRP-targeting therapies, which directly address a mechanism now understood to be central to migraine biology.<\/p>\n Two forms exist:<\/p>\n What makes this shift notable is that the American Headache Society updated its clinical guidance to recognise CGRP-targeting therapies as a first-line<\/strong> preventive option \u2014 meaning patients no longer need to try and fail older medications first before qualifying for them. This reflects a strong and growing body of evidence on their effectiveness and, notably, their tolerability, which tends to be better than some older preventive drug classes.<\/p>\n For chronic migraine \u2014 defined as 15 or more headache days a month, with at least 8 being migrainous \u2014 onabotulinumtoxin A injections administered by a specialist every 12 weeks are an established and effective preventive option, generally reserved for this more severe pattern rather than episodic migraine.<\/p>\n No medication works in isolation from lifestyle factors, and doctors typically pair any drug regimen with:<\/p>\nUnderstanding Migraine Before Treating It<\/h2>\n
Acute Treatments: Stopping an Attack in Progress<\/h2>\n
Over-the-Counter Pain Relievers<\/h3>\n
Triptans<\/h3>\n
\n
Gepants: A Newer Acute Option<\/h3>\n
\n
Ergotamines<\/h3>\n
Anti-Nausea Medications<\/h3>\n
Preventive Treatments: Reducing Attack Frequency<\/h2>\n
Established Preventive Options<\/h3>\n
\n
CGRP-Targeting Therapies<\/h3>\n
\n
OnabotulinumtoxinA (Botox)<\/h3>\n
Lifestyle Measures That Support Medication<\/h2>\n
\n
How Doctors Choose a Treatment Plan<\/h2>\n